Articles by Disease (Lymphoma)

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 8
Page: 187-198
Author(s): Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link and Juan F.M. Leal

Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 8
Page: 207-222
Author(s): G. Del Poeta, A. Bruno, M. I. Del Principe, A. Venditti, L. Maurillo, F. Buccisano, R. Stasi, B. Neri, F. Luciano, A. Siniscalchi, P. de Fabritiis and S. Amadori

Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer

Journal: Current Cancer Drug Targets
Volume: 8
Page: 223-229
Author(s): Greg Finn and Kun Ping Lu

Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice

Journal: Current Cancer Drug Targets
Volume: 8
Page: 230-242
Author(s): Cristina Mastini, Pablo D. Becker, Manuela Iezzi, Claudia Curcio, Piero Musiani, Guido Forni, Federica Cavallo and Carlos A. Guzman

Emerging Breast Cancer Biomarkers

Journal: Current Cancer Therapy Reviews
Volume: 4
Page: 79-85
Author(s): Stephanie A. Laversin, Amanda K. Miles, Graham R. Ball and Robert C. Rees

Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches

Journal: Current Cancer Therapy Reviews
Volume: 4
Page: 96-104
Author(s): Dirk Schadendorf, Jochen Utikal, Balwir Matharoo-Ball, Robert C. Rees and Selma Ugurel

Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders

Journal: Current Cancer Therapy Reviews
Volume: 4
Page: 111-119
Author(s): Evelyna Derhovanessian, Cecile Gouttefangeas, Sven Koch and Graham Pawelec